ClinicalTrials.Veeva

Menu

Multimodal Instrumented Assessment of Post-stroke Elbow

A

Azienda USL Toscana Nord Ovest

Status

Invitation-only

Conditions

Spasticity, Muscle
Stroke
Upper Limb

Treatments

Device: Neuroexsos elbow module

Study type

Interventional

Funder types

Other

Identifiers

NCT04484571
NEEM20160118

Details and patient eligibility

About

The proposed clinical trial will employ the NEUROExos Elbow Module (NEEM), an active robotic exoskeleton, for the passive mobilization and active training of elbow flexion and extension in 60 sub-acute and chronic stroke patients with motor impairments (hemiparesis and/or spasticity) of the right arm. The study protocol is a randomized controlled trial consisting of a 4-week functional rehabilitation program, with both clinical and robotically instrumented assessments to be conducted at baseline and post-treatment.

Full description

The reliable assessment, attribution, and alleviation of upper-limb joint stiffness are essential clinical objectives in the early rehabilitation from stroke and other neurological disorders, to prevent the progression of neuromuscular pathology and enable proactive physiotherapy towards functional recovery. However, the current clinical evaluation and treatment of this stiffness (and underlying muscle spasticity) are severely limited by their dependence on subjective evaluation and manual limb mobilization, thus rendering the evaluation imprecise and the treatment insufficiently tailored to the specific pathologies and residual capabilities of individual patients. To address these needs, the proposed clinical trial will employ the NEUROExos Elbow Module (NEEM), an active robotic exoskeleton, for the passive mobilization and active training of elbow flexion and extension in stroke patients with motor impairments (hemiparesis and/or spasticity) of the right arm. The study protocol provide a functional rehabilitation program, with both clinical and robotically instrumented assessments to be conducted at baseline and post-treatment.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Upper limb spasticity due to neurological impairment;
  • Cognitive abilities sufficient for understanding instructions;
  • Absence of severe pain assessed as Visual Analogic Score (VAS) < 4 (range 0-10).

Exclusion criteria

  • Unstable general clinical conditions;
  • Inability to keep sitting posture;
  • Tendon retractions limiting upper limb joints range of motion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Robotic treatment
Experimental group
Description:
Patients receive 4 weeks of elbow rehabilitation treatment provided by the NEEM robotic elbow exoskeleton
Treatment:
Device: Neuroexsos elbow module
Conventional treatment
Active Comparator group
Description:
Patients receive 4 weeks of elbow conventional rehabilitation treatment matched in time
Treatment:
Device: Neuroexsos elbow module

Trial contacts and locations

1

Loading...

Central trial contact

Nicola Vitiello, Prof; Federico Posteraro, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems